Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders (SCIN-C)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00624325
Recruitment Status : Completed
First Posted : February 27, 2008
Last Update Posted : March 11, 2011
Sponsor:
Information provided by:
Foundation for Liver Research

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 2010
Actual Study Completion Date : December 2010